APA (7th ed.) Citation

AY, A., SA, A., HO, A., Z, A., MAY, A., Y, B., . . . AM, H. (2026). Cardiovascular medications and treatment outcomes in multiple myeloma: Insights from phase III clinical trials. Scientific reports, 16(1), . https://doi.org/10.1038/s41598-026-37464-4

Chicago Style (17th ed.) Citation

AY, Abuhelwa, et al. "Cardiovascular Medications and Treatment Outcomes in Multiple Myeloma: Insights from Phase III Clinical Trials." Scientific Reports 16, no. 1 (2026). https://doi.org/10.1038/s41598-026-37464-4.

MLA (9th ed.) Citation

AY, Abuhelwa, et al. "Cardiovascular Medications and Treatment Outcomes in Multiple Myeloma: Insights from Phase III Clinical Trials." Scientific Reports, vol. 16, no. 1, 2026, https://doi.org/10.1038/s41598-026-37464-4.